Analyst Ranking
Top 17%
#814 out of 4861 analysts
Average Return
+10%
Win Rate
48%20 out of 42
Risk vs Reward
Poor
Good

Rachel Vatnsdal's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Adaptive Biotechnologies CorpADPT
+130.50%$3.18$7.33
2024-05-08 -
2025-04-17
Strong Buy
Adaptive Biotechnologies CorpADPT
+110.35%$3.96$8.33
2024-02-15 -
2025-02-14
Strong Buy
Amyris IncAMRSQ
+97.28%$1.84$0.05
2022-11-10 -
2023-08-18
Strong Sell
Myriad Genetics IncMYGN
+71.32%$26.64$7.64
2024-08-07 -
2025-04-17
Strong Sell
Tempus Ai IncTEM
+71.30%$34.50$59.10
2024-07-09 -
2025-02-25
Strong Buy

Rachel Vatnsdal's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Envista Holdings CorpNVST
4Hold$19.00+25.16%Maintains
2 months ago
Waters CorpWAT
4Hold$390.00+21.49%Maintains
2 months ago
Tempus Ai IncTEM
3Hold$55.00+35.97%Downgrades
2 months ago
Repligen CorpRGEN
5Strong Buy$200.00+53.85%Maintains
2 months ago
Guardant Health IncGH
1Strong Buy$55.00+22.30%Maintains
2 months ago
10x Genomics IncTXG
3Hold$12.00+59.79%Maintains
2 months ago
Twist Bioscience CorpTWST
1Strong Sell$40.00+8.70%Maintains
3 months ago
Agilent Technologies IncA
6Strong Buy$160.00+56.13%Maintains
5 months ago
Thermo Fisher Scientific IncTMO
8Strong Buy$670.00+56.73%Maintains
7 months ago
Henry Schein IncHSIC
3Strong Buy$80.00+23.59%Maintains
8 months ago
Myriad Genetics IncMYGN
3Strong Sell$20.00+161.78%Maintains
8 months ago
Mettler Toledo International IncMTD
2Hold$1,400.00+39.31%Maintains
9 months ago
Adaptive Biotechnologies CorpADPT
4Strong Buy$6.00-18.14%Maintains
9 months ago
Revvity IncRVTY
3Hold$120.00+30.69%Maintains
9 months ago
Akoya Biosciences IncAKYA
1Strong Buy$10.00N/AMaintains
a year ago
Bruker CorpBRKR
2Strong Buy$90.00N/AUpgrades
a year ago
Danaher CorpDHR
4Strong Buy$270.00N/AMaintains
a year ago
Catalent IncCTLT
1Hold$45.00N/ADowngrades
2 years ago
Amyris IncAMRSQ
2Strong SellN/AN/ADowngrades
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.